Counselors in Douglas, MA Accepting Medicare
4 Counselors found. Showing 1 - 4
 Paula K Russo, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 41 Oak St., Douglas, MA 01516 Phone: 978-250-1560 Fax: 508-476-3051 |
Danya Lee Butterfield, BSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 53 Birch St, Douglas, MA 01516 Phone: 508-843-2079 |
Jillian Alfeo Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 306 Main St, Douglas, MA 01516 Phone: 617-347-9199 |
 Patrick Charles Remington Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 121 Franklin St, Douglas, MA 01516 Phone: 508-415-9120 |
News Archive
MMJ Labs launches VibraCool Massaging Ice Therapy for joint and muscle pain relief
MMJ Labs LLC., industry leaders in non-invasive pain relief, have announced the launch of their newest product, VibraCool Massaging Ice Therapy. VibraCool incorporates Cool-Pulse technology, leveraging the physiologic pain relievers of high frequency vibration and ice in a product optimized for athletes and chronic joint pain sufferers.
Functional decline highly prevalent in older adults initiating dialysis
A new study published in CJASN found that functional decline within the first 6 months after initiating dialysis was highly prevalent in older adults at 17 centers in Netherlands, and the risk was higher in those with advanced age and frailty.
SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study
Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.
ReVision Optics initiates US clinical trial of PresbyLens corneal inlay
ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.
› Verified 2 days ago